Maxcyte (MXCT) Inventory (2020 - 2026)

Maxcyte (MXCT) has 7 years of Inventory data on file, last reported at $7.6 million in Q1 2026.

• Quarterly Inventory fell 7.77% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.6 million (down 7.77% YoY) and the FY2025 annual result came in at $7.5 million, down 15.34% from the prior year.
• Inventory advanced to $7.6 million in Q1 2026 per MXCT's latest filing, from $7.5 million in the prior quarter.
• Across five years, Inventory topped out at $12.5 million in Q3 2023 and bottomed at $6.6 million in Q1 2022.
• The 5-year median for Inventory is $8.6 million (2022), against an average of $9.3 million.
• The widest annual swing landed in 2022, when Inventory soared 90.71%; it then plunged 30.82% in 2025.
• Tracing MXCT's Inventory over 5 years: stood at $8.6 million in 2022, then surged by 42.51% to $12.2 million in 2023, then retreated by 27.11% to $8.9 million in 2024, then slipped by 15.34% to $7.5 million in 2025, then climbed by 1.11% to $7.6 million in 2026.
• Per Business Quant, the three latest MXCT Inventory figures stand at $7.6 million (Q1 2026), $7.5 million (Q4 2025), and $7.6 million (Q3 2025).

Peer Comparison